Wave Life Sci Ord Sh (WVE)

$5.95 -0.30 (-4.80%)
Market Cap 1.20B
Revenue (ttm) 42.73M
Net Income (ttm) -204.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -478.31%
Debt to Equity Ratio 0.00
Volume 2,411,000
Avg Vol 3,702,222
Day's Range N/A - N/A
Shares Out 192.40M
Stochastic %K 35%
Beta -1.29
Analysts Strong Sell
Price Target $22.93

Company Profile

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of...

Industry: Biotechnology
Sector: Healthcare
Phone: 65 6236 3388
Address:
Marina One East Tower, 7 Straits View No.12-00, Singapore, Singapore
buymoremakemore
buymoremakemore Jul. 13 at 9:15 PM
$WVE Bought another 5k shares
1 · Reply
Relee187200
Relee187200 Jul. 10 at 3:01 PM
$WVE Recent article is just a regurgitation of old news.
0 · Reply
Relee187200
Relee187200 Jul. 10 at 2:34 PM
$WVE What happened? Any news?
0 · Reply
Relee187200
Relee187200 Jul. 10 at 2:09 PM
$WVE Any reason for this drop?
0 · Reply
PepCF
PepCF Jul. 6 at 11:30 AM
$WVE 6 - 7
0 · Reply
CliffordCapital
CliffordCapital Jul. 4 at 9:21 AM
$PLX happy July 4th to my American brothers and sisters!! May god bless you $WVE $IREN $EOSE $VSTM
0 · Reply
Rawtoast
Rawtoast Jul. 2 at 3:56 PM
$WVE let’s go!!!
0 · Reply
BioRich
BioRich Jul. 1 at 4:45 PM
$CRMD Stocktwits Q2 Quarterly Filing: @BioRich Top 50 portfolio positions: 1) GUTS 2) ABVX 3) IBRX 4) ALT 5) KYTX 6) DAVE 7) CADL 8) MIST 9) UEC 10) OTLK 11) CAPR 12) TGTX 13) SABS 14) NVAX 15) LEGN 16) VKTX 17) OCUL 18) SOFI 19) BBIO 20) SGP 21) VNDA 22) SHAZ 23) NRXP 24) GPCR 25) EWTX 26) TLSA 27) SKM 28) MLTX 29) SNDX 30) JMIA 31) NKTR 32) VVOS 33) RGNX 35) ARRNF 36) CRMD 37) $WVE 38) $NUVB 39) $SMMT 40) ANNX 41) CGON 42) TEM 43) IVA 44) PSN 45) LGND 46) IMVT 47) MPLT 48)NNE 49) ARDX 50) COGT If I own it, I believe in it. What am I missing? Hold too much? Not enough? Look forward to your feedback! Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
6 · Reply
PepCF
PepCF Jun. 30 at 9:46 AM
$WVE It’s almost the only one of the latest RA Capital investments that’s still below the entry price.
0 · Reply
jumptime
jumptime Jun. 29 at 6:48 PM
$WVE New at $5.68
0 · Reply
Latest News on WVE
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

Jul 7, 2026, 4:15 PM EDT - 6 days ago

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

Wave Life Sciences initiates multidose portion of Inlight trial

2026-06-24T13:05:39.000Z - 19 days ago

Wave Life Sciences initiates multidose portion of Inlight trial

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases

Jun 24, 2026, 8:30 AM EDT - 19 days ago

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases

Wave Life Sciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 5 weeks ago

Wave Life Sciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Wave Life Sciences Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 10:30 AM EDT - 5 weeks ago

Wave Life Sciences Transcript: Jefferies Global Healthcare Conference 2026

Wave Life Sciences to Present at Upcoming Investor Conferences

Jun 1, 2026, 8:30 AM EDT - 6 weeks ago

Wave Life Sciences to Present at Upcoming Investor Conferences

Wave Life Sciences Ltd. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses

May 27, 2026, 8:41 AM EDT - 6 weeks ago

Wave Life Sciences Ltd. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses

Wave Life Sciences Transcript: RBC Capital Markets Global Healthcare Conference 2026

May 20, 2026, 8:00 AM EDT - 7 weeks ago

Wave Life Sciences Transcript: RBC Capital Markets Global Healthcare Conference 2026

Wave Life Sciences price target raised to $14 from $13 at Wells Fargo

2026-05-20T10:30:59.000Z - 7 weeks ago

Wave Life Sciences price target raised to $14 from $13 at Wells Fargo

Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1

May 19, 2026, 9:49 AM EDT - 7 weeks ago

Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1

Wave Life Sciences price target lowered to $13 from $18 at H.C. Wainwright

2026-05-19T10:45:09.000Z - 7 weeks ago

Wave Life Sciences price target lowered to $13 from $18 at H.C. Wainwright

Wave Life Sciences Transcript: Study update

May 18, 2026, 5:30 PM EDT - 2 months ago

Wave Life Sciences Transcript: Study update

Wave Life Sciences Press release: Study update

May 18, 2026, 5:30 PM EDT - 2 months ago

Wave Life Sciences Press release: Study update

Wave Life Sciences Slides: Study update

May 18, 2026, 5:30 PM EDT - 2 months ago

Wave Life Sciences Slides: Study update

Wave Life Sciences announces updated data from RestorAATion-2 trial of WVE-006

2026-05-18T20:40:07.000Z - 2 months ago

Wave Life Sciences announces updated data from RestorAATion-2 trial of WVE-006

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing

May 18, 2026, 4:30 PM EDT - 2 months ago

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

May 13, 2026, 4:05 PM EDT - 2 months ago

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

Wave Life Sciences Proxy statement: Proxy filing

May 7, 2026, 8:00 AM EDT - 2 months ago

Wave Life Sciences Proxy statement: Proxy filing

Wave Life Sciences price target lowered to $24 from $30 at Citi

2026-05-04T11:00:31.000Z - 2 months ago

Wave Life Sciences price target lowered to $24 from $30 at Citi

Wave Life Sciences Proxy statement: Proxy filing

May 1, 2026, 8:00 AM EDT - 2 months ago

Wave Life Sciences Proxy statement: Proxy filing

Wave Life Sciences price target lowered to $43 from $52 at Canaccord

2026-04-30T13:11:32.000Z - 2 months ago

Wave Life Sciences price target lowered to $43 from $52 at Canaccord

Wave Life Sciences price target lowered to $19 from $21 at BofA

2026-04-29T12:23:04.000Z - 2 months ago

Wave Life Sciences price target lowered to $19 from $21 at BofA

Wave Life Sciences assumed with a Buy at Truist

2026-04-29T09:10:14.000Z - 2 months ago

Wave Life Sciences assumed with a Buy at Truist

Wave Life Sciences price target lowered to $36 from $39 at Clear Street

2026-04-28T16:35:16.000Z - 2 months ago

Wave Life Sciences price target lowered to $36 from $39 at Clear Street

Wave Life Sciences Earnings Call Transcript: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 2 months ago

Wave Life Sciences Earnings Call Transcript: Q1 2026

Wave Life Sciences Earnings release: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 2 months ago

Wave Life Sciences Earnings release: Q1 2026

Wave Life Sciences Quarterly report: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 2 months ago

Wave Life Sciences Quarterly report: Q1 2026

Wave Life Sciences reports Q1 EPS (13c), consensus (31c)

2026-04-28T11:59:24.000Z - 2 months ago

Wave Life Sciences reports Q1 EPS (13c), consensus (31c)

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

Apr 28, 2026, 7:30 AM EDT - 2 months ago

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

Apr 22, 2026, 8:30 AM EDT - 2 months ago

Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

Wave Life Sciences announces hearing on proposed redomicilation

2026-04-21T20:05:17.000Z - 2 months ago

Wave Life Sciences announces hearing on proposed redomicilation

Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States

Apr 21, 2026, 4:01 PM EDT - 2 months ago

Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States

Wave Life Sciences Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Wave Life Sciences Proxy statement: Proxy filing

Wave Life Sciences Announces Proposed Redomiciliation to the United States

Apr 15, 2026, 4:01 PM EDT - 3 months ago

Wave Life Sciences Announces Proposed Redomiciliation to the United States

Wave Life Sciences Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

Wave Life Sciences Proxy statement: Proxy filing

Wave Life Sciences Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

Wave Life Sciences Proxy statement: Proxy filing

Wave Life Sciences price target lowered to $18 from $30 at H.C. Wainwright

2026-04-14T10:21:03.000Z - 3 months ago

Wave Life Sciences price target lowered to $18 from $30 at H.C. Wainwright

Wave Life Sciences stock crash: why analyst sees a buying opportunity

Mar 26, 2026, 3:00 PM EDT - 3 months ago

Wave Life Sciences stock crash: why analyst sees a buying opportunity

WAVE LIFE SCIENCES Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Mar 26, 2026, 10:28 AM EDT - 3 months ago

WAVE LIFE SCIENCES Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Wave Life Sciences shares plunge as data for high dose of obesity drug disappoints

Mar 26, 2026, 9:33 AM EDT - 3 months ago

Wave Life Sciences shares plunge as data for high dose of obesity drug disappoints

Wave Life Sciences Transcript: Study result

Mar 26, 2026, 8:30 AM EDT - 3 months ago

Wave Life Sciences Transcript: Study result

Wave Life Sciences Press release: Study result

Mar 26, 2026, 8:30 AM EDT - 3 months ago

Wave Life Sciences Press release: Study result

Wave Life Sciences Slides: Study result

Mar 26, 2026, 8:30 AM EDT - 3 months ago

Wave Life Sciences Slides: Study result

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

Mar 26, 2026, 7:30 AM EDT - 3 months ago

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

FDA reversals leave investors worrying about the fates of other experimental drugs

Mar 6, 2026, 11:33 AM EST - 4 months ago

FDA reversals leave investors worrying about the fates of other experimental drugs

DNLI MRNA RGNX

Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference

Mar 5, 2026, 8:30 AM EST - 4 months ago

Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference

Wave Life Sciences Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 26, 2026, 2:40 PM EST - 4 months ago

Wave Life Sciences Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Wave Life Sciences Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Wave Life Sciences Earnings Call Transcript: Q4 2025

Wave Life Sciences Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Wave Life Sciences Annual report: Q4 2025

Wave Life Sciences Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Wave Life Sciences Earnings release: Q4 2025

Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 26, 2026, 7:30 AM EST - 4 months ago

Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 23, 2026, 8:30 AM EST - 5 months ago

Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026

Feb 19, 2026, 8:30 AM EST - 5 months ago

Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026

Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency

Feb 2, 2026, 7:30 AM EST - 5 months ago

Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency

Wave Life Sciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 5:15 PM EST - 6 months ago

Wave Life Sciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Wave Life Sciences Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 5:15 PM EST - 6 months ago

Wave Life Sciences Slides: 44th Annual J.P. Morgan Healthcare Conference

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio

Jan 12, 2026, 7:30 AM EST - 6 months ago

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio

Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 8:30 AM EST - 6 months ago

Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Why Did Wave Life Sciences Surge 147%?

Dec 15, 2025, 6:30 AM EST - 7 months ago

Why Did Wave Life Sciences Surge 147%?

Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Dec 9, 2025, 9:50 PM EST - 7 months ago

Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Dec 8, 2025, 4:01 PM EST - 7 months ago

Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Wave Life Sciences Transcript: Study Update

Dec 8, 2025, 8:30 AM EST - 7 months ago

Wave Life Sciences Transcript: Study Update

Wave Life Sciences Press release: Study Update

Dec 8, 2025, 8:30 AM EST - 7 months ago

Wave Life Sciences Press release: Study Update

Wave Life Sciences Slides: Study Update

Dec 8, 2025, 8:30 AM EST - 7 months ago

Wave Life Sciences Slides: Study Update

Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss

Dec 8, 2025, 7:30 AM EST - 7 months ago

Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

Dec 7, 2025, 4:00 PM EST - 7 months ago

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

Wave Life Sciences Transcript: Jefferies London Healthcare Conference 2025

Nov 20, 2025, 4:00 AM EST - 8 months ago

Wave Life Sciences Transcript: Jefferies London Healthcare Conference 2025

Wave Life Sciences Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 11, 2025, 10:00 AM EST - 8 months ago

Wave Life Sciences Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Wave Life Sciences Earnings Call Transcript: Q3 2025

Nov 10, 2025, 8:30 AM EST - 8 months ago

Wave Life Sciences Earnings Call Transcript: Q3 2025

Wave Life Sciences Quarterly report: Q3 2025

Nov 10, 2025, 8:30 AM EST - 8 months ago

Wave Life Sciences Quarterly report: Q3 2025

Wave Life Sciences Earnings release: Q3 2025

Nov 10, 2025, 8:30 AM EST - 8 months ago

Wave Life Sciences Earnings release: Q3 2025

Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 10, 2025, 7:30 AM EST - 8 months ago

Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025

Nov 4, 2025, 8:30 PM EST - 8 months ago

Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025

Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025

Nov 4, 2025, 8:30 AM EST - 8 months ago

Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Oct 29, 2025, 10:50 PM EDT - 9 months ago

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Oct 29, 2025, 4:15 PM EDT - 9 months ago

Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Wave Life Sciences Transcript: Research Day

Oct 29, 2025, 10:00 AM EDT - 9 months ago

Wave Life Sciences Transcript: Research Day

Wave Life Sciences Press release: Research Day

Oct 29, 2025, 10:00 AM EDT - 9 months ago

Wave Life Sciences Press release: Research Day

Wave Life Sciences Slides: Research Day

Oct 29, 2025, 10:00 AM EDT - 9 months ago

Wave Life Sciences Slides: Research Day

Wave Life Sciences Transcript: Chardan’s 9th Annual Genetic Medicines Conference

Oct 21, 2025, 1:00 PM EDT - 9 months ago

Wave Life Sciences Transcript: Chardan’s 9th Annual Genetic Medicines Conference

Wave Life Sciences Transcript: Stifel Virtual Cardiometabolic Forum

Sep 30, 2025, 1:00 PM EDT - 10 months ago

Wave Life Sciences Transcript: Stifel Virtual Cardiometabolic Forum

Wave Life Sciences Transcript: Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Sep 24, 2025, 2:50 PM EDT - 10 months ago

Wave Life Sciences Transcript: Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences

Sep 18, 2025, 8:30 AM EDT - 10 months ago

Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences

Wave Life Sciences Transcript: Status Update

Sep 3, 2025, 8:30 AM EDT - 11 months ago

Wave Life Sciences Transcript: Status Update

Wave Life Sciences Press release: Status Update

Sep 3, 2025, 8:30 AM EDT - 11 months ago

Wave Life Sciences Press release: Status Update

Wave Life Sciences Slides: Status Update

Sep 3, 2025, 8:30 AM EDT - 11 months ago

Wave Life Sciences Slides: Status Update

Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

Sep 3, 2025, 7:30 AM EDT - 11 months ago

Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

Wave Life Sciences Earnings Call Transcript: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Earnings Call Transcript: Q2 2025

Wave Life Sciences Quarterly report: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Quarterly report: Q2 2025

Wave Life Sciences Earnings release: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Earnings release: Q2 2025

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 30, 2025, 7:30 AM EDT - 1 year ago

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025

Jul 23, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025

Wave Life Sciences Proxy statement: Proxy Filing

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Wave Life Sciences Proxy statement: Proxy Filing

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions

Jun 20, 2025, 4:01 PM EDT - 1 year ago

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions

Wave Life Sciences Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 3:45 PM EDT - 1 year ago

Wave Life Sciences Transcript: Jefferies Global Healthcare Conference 2025

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference

May 29, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer

May 28, 2025, 8:00 AM EDT - 1 year ago

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer

Wave Life Sciences Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Earnings Call Transcript: Q1 2025

Wave Life Sciences Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Quarterly report: Q1 2025

Wave Life Sciences Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Earnings release: Q1 2025

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

May 8, 2025, 7:30 AM EDT - 1 year ago

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

Wave Life Sciences Slides: Corporate presentation

May 8, 2025, 7:00 AM EDT - 1 year ago

Wave Life Sciences Slides: Corporate presentation

Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025

May 1, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025

Wave Life Sciences Transcript: Study Result

Mar 26, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Transcript: Study Result

Wave Life Sciences Press release: Study Result

Mar 26, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Press release: Study Result

Wave Life Sciences Slides: Study Result

Mar 26, 2025, 8:30 AM EDT - 1 year ago

Wave Life Sciences Slides: Study Result

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531

Mar 26, 2025, 7:30 AM EDT - 1 year ago

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531

Wave Life Sciences Earnings Call Transcript: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Wave Life Sciences Earnings Call Transcript: Q4 2024

Wave Life Sciences Annual report: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Wave Life Sciences Annual report: Q4 2024

Wave Life Sciences Earnings release: Q4 2024

Mar 4, 2025, 8:30 AM EST - 1 year ago

Wave Life Sciences Earnings release: Q4 2024

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 4, 2025, 7:30 AM EST - 1 year ago

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025

Feb 25, 2025, 8:30 AM EST - 1 year ago

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity

Feb 6, 2025, 8:30 AM EST - 1 year ago

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity

Wave Life Sciences Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 12:45 PM EST - 1 year ago

Wave Life Sciences Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Wave Life Sciences Slides: FY 2025

Jan 13, 2025, 12:45 PM EST - 1 year ago

Wave Life Sciences Slides: FY 2025

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity

Dec 23, 2024, 8:30 AM EST - 1 year ago

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 16, 2024, 8:30 AM EST - 1 year ago

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Wave Life Sciences Transcript: Citi's 2024 Global Healthcare Conference

Dec 4, 2024, 1:00 PM EST - 1 year ago

Wave Life Sciences Transcript: Citi's 2024 Global Healthcare Conference

Wave Life Sciences Transcript: 7th Annual Evercore ISI HealthCONx Healthcare Conference

Dec 3, 2024, 3:00 PM EST - 1 year ago

Wave Life Sciences Transcript: 7th Annual Evercore ISI HealthCONx Healthcare Conference

Wave Life Sciences Transcript: Jefferies London Healthcare Conference 2024

Nov 20, 2024, 11:30 AM EST - 1 year ago

Wave Life Sciences Transcript: Jefferies London Healthcare Conference 2024

Wave Life Sciences to Present at Jefferies London Healthcare Conference

Nov 15, 2024, 8:30 AM EST - 1 year ago

Wave Life Sciences to Present at Jefferies London Healthcare Conference

Wave Life Sciences Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Wave Life Sciences Earnings Call Transcript: Q3 2024

Wave Life Sciences Quarterly report: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Wave Life Sciences Quarterly report: Q3 2024

Wave Life Sciences Earnings release: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Wave Life Sciences Earnings release: Q3 2024

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs

Oct 30, 2024, 4:45 PM EDT - 1 year ago

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs

buymoremakemore
buymoremakemore Jul. 13 at 9:15 PM
$WVE Bought another 5k shares
1 · Reply
Relee187200
Relee187200 Jul. 10 at 3:01 PM
$WVE Recent article is just a regurgitation of old news.
0 · Reply
Relee187200
Relee187200 Jul. 10 at 2:34 PM
$WVE What happened? Any news?
0 · Reply
Relee187200
Relee187200 Jul. 10 at 2:09 PM
$WVE Any reason for this drop?
0 · Reply
PepCF
PepCF Jul. 6 at 11:30 AM
$WVE 6 - 7
0 · Reply
CliffordCapital
CliffordCapital Jul. 4 at 9:21 AM
$PLX happy July 4th to my American brothers and sisters!! May god bless you $WVE $IREN $EOSE $VSTM
0 · Reply
Rawtoast
Rawtoast Jul. 2 at 3:56 PM
$WVE let’s go!!!
0 · Reply
BioRich
BioRich Jul. 1 at 4:45 PM
$CRMD Stocktwits Q2 Quarterly Filing: @BioRich Top 50 portfolio positions: 1) GUTS 2) ABVX 3) IBRX 4) ALT 5) KYTX 6) DAVE 7) CADL 8) MIST 9) UEC 10) OTLK 11) CAPR 12) TGTX 13) SABS 14) NVAX 15) LEGN 16) VKTX 17) OCUL 18) SOFI 19) BBIO 20) SGP 21) VNDA 22) SHAZ 23) NRXP 24) GPCR 25) EWTX 26) TLSA 27) SKM 28) MLTX 29) SNDX 30) JMIA 31) NKTR 32) VVOS 33) RGNX 35) ARRNF 36) CRMD 37) $WVE 38) $NUVB 39) $SMMT 40) ANNX 41) CGON 42) TEM 43) IVA 44) PSN 45) LGND 46) IMVT 47) MPLT 48)NNE 49) ARDX 50) COGT If I own it, I believe in it. What am I missing? Hold too much? Not enough? Look forward to your feedback! Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
6 · Reply
PepCF
PepCF Jun. 30 at 9:46 AM
$WVE It’s almost the only one of the latest RA Capital investments that’s still below the entry price.
0 · Reply
jumptime
jumptime Jun. 29 at 6:48 PM
$WVE New at $5.68
0 · Reply
cninc
cninc Jun. 28 at 4:03 PM
$WVE https://www.acc.org/latest-in-cardiology/journal-scans/2026/06/08/17/44/follow-up-of-central-direct-plus?fbclid=IwY2xjawSuJH9leHRuA2FlbQIxMABicmlkETFiT05SejZ2OXNpTzVYTDlsc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHiSD6tYlIqWcOF8hcIFWJmjd_7-2t5guoLQCb2poTHUdn9FoxdSghBf5UaI5_aem_KXbP-fWSs8YF21po-zj3tQ
0 · Reply
Benitocalixto
Benitocalixto Jun. 26 at 2:10 PM
$WVE Excellent news!! The shareholders voted in favor of the Wave Redomiciliation Proposal and it by was approved by the Singapore law and order of the Singapore High Court. The company will seek requisite approval by the Singapore High Court - the redomiciliation will take effect in mid-2026.
1 · Reply
cninc
cninc Jun. 24 at 9:55 PM
$WVE https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-initiation-phase-2a-portion
0 · Reply
Bioboarder
Bioboarder Jun. 24 at 8:12 PM
$WVE How did the vote go at the special meeting 22 Juli ? Thanks in advance
1 · Reply
BioRich
BioRich Jun. 24 at 8:11 PM
$EWTX Starting to hit the upward channel and should start hitting many of the BO speculation channels. Can't believe we're only sitting on 619 followers here. Any of my folks from historical favorites like $SRPT, $CAPR, $WVE $SLBD in Edgewise as well? Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
0 · Reply
CliffordCapital
CliffordCapital Jun. 24 at 5:34 PM
$VSTM $KYTX $PRME $WVE … all dragged up with XBI power.. once xbi goes Down all four fill fade hard. No I am not a bear I am actually long in all these but price action has been extremely poor on this xbi +10% move. Ridiculous
1 · Reply
flyinghollaender
flyinghollaender Jun. 24 at 3:45 PM
$WVE whats the next catalyst here
0 · Reply
PepCF
PepCF Jun. 18 at 11:36 AM
$WVE SELLING panic is losing steam. MACD triggered a buy signal on June 9th and RSI is officially out of extreme oversold territory. In derivatives, volume is heavily skewed toward bullish calls. Solid support at $5.00 - $5.40, with resistance sitting at $6.20 - $6.50. Catalysts coming soon. Today our competitor $BEAM got FDA clearance... We are next!
0 · Reply
rahmanoof
rahmanoof Jun. 17 at 6:53 PM
$WVE someone bought 1k calls expiring tomorrow, hope he knows what he is doing
1 · Reply
wowwwwww2
wowwwwww2 Jun. 16 at 8:00 PM
$WVE this turd on the continued drop
0 · Reply
PepCF
PepCF Jun. 16 at 11:38 AM
$WVE 6 - 7
1 · Reply
johnnygogogo
johnnygogogo Jun. 15 at 5:47 PM
$WVE who’s been keeping this out of the XBI? It is more than 3x the minimum mkt cap for inclusion. Will it get added this week?
0 · Reply